OTC:NWBO   Northwest Biotherapeutics, Inc
so there is not much here to do for TA. The price action has been trading sideways since datalock was announced. i like that the general trend is positive. Feels like MMs (or a few big ass fish) are working to keep price action down + profit taking from those who bought in at the lows of $0.14 . Saying MM and Whales bc level 2 data show a bid/ask spread that seems to be intentionally placed to keep price trading within a window.

i have a pretty decent stake in this company. I am no scientist but i like the potential behind their science (to the degree i understand here). Price has reacted according to catalysts.
eg: annnouncing of data lock shot price up to $2.50 before settling at $1.50s and trading sideways but with an upward trend. I think this price action will continue. The outcome in my eyes is very binary--Boom or Bust.

buy: generally, i think any pricing within the $1-2 range is good long term since this still is certainly a gamble at this point. more specifically, would buy shares on the lower end of the trend channel.

boom: $5-10 pps upon postive TLD release, long term (5-10 years) can see this being a big gainer/multi multi bagger.
bust: $0.14 pps upon negative TLD release

biased here but i think boom is more likely than bust, company is operating as if they are sitting on gold but dont want anyone to know it.

Company is worth looking into. Do your own DD. If you find yourself reading the Yahoo forum, chances are you will see a bunch of pumpers and bashers. Almost all the bashers are guys that claim to be warning you bc they are "good samaritans" i dont buy this crap.
Comment: I expect there to be another buy opportunity like the pricing that was pointed out in the above chart. Probably not as deep of a sudden dip.

All it takes is one whale to dump shares and trigger unconfident holders' stop losses, which is what i think happened before. Something like 20mm shares were sold then bought up very quickly when that last massive bear wick happened. this stock is worth watching if you are unaware of it.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.